In July of 2018, The FDA recalled certain lots of Valsartan after finding the probable human carcinogen NDMA had contaminated the drug in a manufacturing facility. This carcinogenic substance has been linked to serious side effects including liver, kidney, colorectal, stomach, and pancreatic cancer, among other types of cancers and serious damage to the liver and kidneys.
The FDA was slow to respond and only recalled drug after 22 other countries had already taken action to remove the medication from their pharmaceutical shelves.
Short-term exposure to NDMA can cause liver damage (such as liver fibrosis and scarring). Long-term exposure can increase the risk of liver, kidney, and lung tumors. According to the Environmental Protection Agency (EPA), NDMA is not currently produced in pure form or commercially used in the United States, except for research purposes. It was formerly used in production of liquid rocket fuel, antioxidants, additives for lubricants, and softeners for copolymers.
If you or a loved one took Valsartan were then diagnosed with:
You may be entitled to significant compensation from the manufacturer.
There are time deadlines to file a claim so don’t wait – act now.
Free Valsartan Legal Consultation
Thank you for submitting your information.